The first assessment of hepatitis E virus seroprevalence in northern Portugal.
DOI:
https://doi.org/10.20344/amp.2366Abstract
Hepatitis E is an enterically transmitted acute viral hepatitis, etiologically associated with a recently characterized virus, the hepatitis E virus (HEV). Outbreaks mainly occur in developing countries and as sporadic cases in endemic regions. The authors present the first serological assessment in northern Portugal to assess the presence of anti HEV IgG, using the Elisa test, the EIA and HEV Abbott, in samples from 50 blood donors and 103 chronic liver disease patients. In 2 blood donors (4%) and in 7 (6.8%) liver patients, the HEV antibody was detected with optic densities/cut off always below 2.5. Only one patient had a sojourn in an endemic region; the presence of anti-HEV was not significantly associated with other hepatotropic viruses. With this test the authors conclude that 4% of our blood donors are seropositive for anti-HEV antibody and that this percentage is not significantly higher in chronic liver disease patients (6.8%). They also think that a new generation of immunological assays, designed for serological diagnosis of HEV infection, will provide a further understanding of hepatitis E epidemiology.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.